HOOKIPA Pharma IncNASDAQ:HOOKNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7801
- TODAY'S CHANGE (%)-0.0199 (-2.4875%)
- Bid / Lots0.7803/ 172
- Ask / Lots0.7951/ 39
- Open / Previous Close0.8000 / 0.8000
- Day Range
- 52 Week Range
- Volume737,746
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HOOK |
|---|---|---|
| 09:32 ET | 27855 | 0.81 |
| 09:34 ET | 400 | 0.8101 |
| 09:36 ET | 600 | 0.8101 |
| 09:38 ET | 3703 | 0.81 |
| 09:39 ET | 729 | 0.8126 |
| 09:41 ET | 3854 | 0.8151 |
| 09:43 ET | 3240 | 0.8293 |
| 09:45 ET | 4012 | 0.815 |
| 09:48 ET | 7830 | 0.815 |
| 09:50 ET | 4500 | 0.805 |
| 09:52 ET | 10470 | 0.7964 |
| 09:54 ET | 24681 | 0.790001 |
| 09:56 ET | 2902 | 0.7902 |
| 09:57 ET | 5698 | 0.79 |
| 09:59 ET | 1600 | 0.79 |
| 10:01 ET | 6400 | 0.8001 |
| 10:03 ET | 849 | 0.7901 |
| 10:08 ET | 4900 | 0.8 |
| 10:10 ET | 1294 | 0.7947 |
| 10:12 ET | 4250 | 0.8 |
| 10:14 ET | 7925 | 0.8 |
| 10:15 ET | 300 | 0.799 |
| 10:17 ET | 1090 | 0.7901 |
| 10:19 ET | 734 | 0.7999 |
| 10:21 ET | 298 | 0.79 |
| 10:24 ET | 290 | 0.7911 |
| 10:26 ET | 806 | 0.791 |
| 10:28 ET | 47490 | 0.8 |
| 10:30 ET | 6710 | 0.8 |
| 10:32 ET | 600 | 0.808856 |
| 10:33 ET | 3200 | 0.8 |
| 10:35 ET | 5100 | 0.8 |
| 10:37 ET | 33557 | 0.805 |
| 10:39 ET | 2150 | 0.809999 |
| 10:42 ET | 7228 | 0.806 |
| 10:44 ET | 6350 | 0.8 |
| 10:46 ET | 47503 | 0.8 |
| 10:48 ET | 4823 | 0.8 |
| 10:50 ET | 900 | 0.8 |
| 10:51 ET | 22405 | 0.8001 |
| 10:53 ET | 7500 | 0.8 |
| 10:55 ET | 6100 | 0.8 |
| 10:57 ET | 800 | 0.8001 |
| 11:00 ET | 3600 | 0.8 |
| 11:02 ET | 63422 | 0.7811 |
| 11:04 ET | 2150 | 0.789 |
| 11:06 ET | 1112 | 0.78176 |
| 11:08 ET | 2998 | 0.785 |
| 11:09 ET | 2600 | 0.78785 |
| 11:11 ET | 2295 | 0.787098 |
| 11:13 ET | 1400 | 0.7871 |
| 11:15 ET | 5193 | 0.7954 |
| 11:18 ET | 3975 | 0.7984 |
| 11:20 ET | 250 | 0.7901 |
| 11:22 ET | 600 | 0.798199 |
| 11:24 ET | 500 | 0.7901 |
| 11:26 ET | 955 | 0.7977 |
| 11:27 ET | 1000 | 0.7977 |
| 11:31 ET | 2625 | 0.795 |
| 11:33 ET | 100 | 0.7869 |
| 11:38 ET | 1623 | 0.795 |
| 11:40 ET | 2000 | 0.795 |
| 11:42 ET | 500 | 0.784 |
| 11:45 ET | 1600 | 0.792499 |
| 11:47 ET | 584 | 0.792399 |
| 11:49 ET | 200 | 0.79 |
| 11:51 ET | 200 | 0.7901 |
| 11:54 ET | 3400 | 0.7901 |
| 12:00 ET | 127 | 0.7951 |
| 12:02 ET | 600 | 0.7951 |
| 12:03 ET | 1200 | 0.7951 |
| 12:05 ET | 125 | 0.79949 |
| 12:12 ET | 1745 | 0.7995 |
| 12:14 ET | 1900 | 0.795201 |
| 12:16 ET | 2600 | 0.7995 |
| 12:18 ET | 29659 | 0.7951 |
| 12:20 ET | 5525 | 0.795 |
| 12:21 ET | 4255 | 0.795 |
| 12:23 ET | 1700 | 0.7951 |
| 12:27 ET | 800 | 0.795 |
| 12:34 ET | 2310 | 0.7901 |
| 12:36 ET | 1100 | 0.79 |
| 12:38 ET | 1525 | 0.79 |
| 12:39 ET | 1417 | 0.784 |
| 12:41 ET | 100 | 0.7841 |
| 12:43 ET | 481 | 0.7841 |
| 12:45 ET | 105 | 0.784 |
| 12:48 ET | 200 | 0.79 |
| 12:50 ET | 969 | 0.79 |
| 12:52 ET | 390 | 0.7811 |
| 12:54 ET | 100 | 0.7812 |
| 12:59 ET | 241 | 0.786 |
| 01:01 ET | 19167 | 0.79 |
| 01:03 ET | 1555 | 0.795 |
| 01:06 ET | 4280 | 0.79 |
| 01:08 ET | 3100 | 0.795 |
| 01:10 ET | 2200 | 0.795 |
| 01:14 ET | 200 | 0.8014 |
| 01:15 ET | 1200 | 0.8 |
| 01:17 ET | 1200 | 0.8 |
| 01:21 ET | 196 | 0.8077 |
| 01:26 ET | 1600 | 0.7951 |
| 01:28 ET | 4100 | 0.7951 |
| 01:30 ET | 400 | 0.79 |
| 01:32 ET | 100 | 0.795 |
| 01:35 ET | 1386 | 0.79005 |
| 01:37 ET | 8740 | 0.795 |
| 01:42 ET | 425 | 0.7901 |
| 01:44 ET | 158 | 0.7901 |
| 01:48 ET | 364 | 0.79 |
| 01:50 ET | 200 | 0.7824 |
| 01:51 ET | 250 | 0.782 |
| 01:53 ET | 500 | 0.7901 |
| 01:55 ET | 1710 | 0.782101 |
| 01:57 ET | 1120 | 0.782 |
| 02:02 ET | 550 | 0.782 |
| 02:04 ET | 100 | 0.782 |
| 02:06 ET | 600 | 0.7821 |
| 02:08 ET | 3500 | 0.7821 |
| 02:09 ET | 2876 | 0.7821 |
| 02:11 ET | 3941 | 0.7813 |
| 02:13 ET | 3178 | 0.781 |
| 02:15 ET | 3567 | 0.7813 |
| 02:20 ET | 1541 | 0.78833 |
| 02:22 ET | 900 | 0.7883 |
| 02:24 ET | 2380 | 0.786 |
| 02:26 ET | 200 | 0.786 |
| 02:27 ET | 800 | 0.785 |
| 02:29 ET | 200 | 0.789299 |
| 02:31 ET | 5296 | 0.7825 |
| 02:33 ET | 2050 | 0.7825 |
| 02:36 ET | 350 | 0.7826 |
| 02:38 ET | 3790 | 0.7826 |
| 02:40 ET | 1100 | 0.7825 |
| 02:42 ET | 700 | 0.7825 |
| 02:45 ET | 1700 | 0.7826 |
| 02:47 ET | 1177 | 0.7826 |
| 02:49 ET | 500 | 0.7825 |
| 02:54 ET | 500 | 0.7826 |
| 02:56 ET | 14503 | 0.7842 |
| 03:03 ET | 600 | 0.7857 |
| 03:05 ET | 4100 | 0.7858 |
| 03:07 ET | 7297 | 0.7858 |
| 03:12 ET | 3300 | 0.7854 |
| 03:14 ET | 1120 | 0.7842 |
| 03:20 ET | 2400 | 0.78105 |
| 03:21 ET | 1100 | 0.78105 |
| 03:25 ET | 1820 | 0.7805 |
| 03:27 ET | 1120 | 0.7811 |
| 03:30 ET | 1500 | 0.7811 |
| 03:32 ET | 4000 | 0.7811 |
| 03:34 ET | 4791 | 0.7851 |
| 03:36 ET | 200 | 0.7857 |
| 03:38 ET | 100 | 0.78575 |
| 03:39 ET | 12691 | 0.7846 |
| 03:41 ET | 826 | 0.78555 |
| 03:43 ET | 13743 | 0.785 |
| 03:45 ET | 837 | 0.7849 |
| 03:48 ET | 2200 | 0.7812 |
| 03:50 ET | 300 | 0.7811 |
| 03:52 ET | 2300 | 0.781 |
| 03:54 ET | 1200 | 0.781 |
| 03:56 ET | 6906 | 0.7801 |
| 03:57 ET | 14019 | 0.7801 |
| 03:59 ET | 1633 | 0.7801 |
May 23, 2024
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting, from 5:01PM ET on Thursday May 23, 2024 by Dow Jones
5:01PM ET on Thursday May 23, 2024 by Dow Jones
May 21, 2024
DJ HOOKIPA Pharma Price Target Maintained With a $5.00/Share by RBC Capital, from 1:21PM ET on Tuesday May 21, 2024 by Dow Jones
1:21PM ET on Tuesday May 21, 2024 by Dow Jones
May 9, 2024
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights, from 7:01AM ET on Thursday May 09, 2024 by Dow Jones
7:01AM ET on Thursday May 09, 2024 by Dow Jones*DJ HOOKIPA Pharma 1Q EPS 11c >HOOK, from 7:01AM ET on Thursday May 09, 2024 by Dow Jones
7:01AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
HOOKIPA Pharma Inc | 79.2M | 0.0x | --- |
Company Information
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
Contact Information
- Headquarters
- 350 Fifth Avenue, 72Nd Floor, Suite 7240NEW YORK, NY, United States 10118
- Phone
- ---
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $79.2M |
|---|---|
Revenue (TTM) | $53.6M |
Shares Outstanding | 99.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-0.59 |
Book Value | $0.91 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -119.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
